What is CarThera?
Founded in 2010 and headquartered in Paris, France, CarThera is at the forefront of developing innovative ultrasound-based medical solutions. The company's technological advancements aim to address critical needs within the healthcare industry, positioning it as a key player in the medical device market. This latest capital infusion is expected to accelerate its growth and expand its reach.
How much funding has CarThera raised?
CarThera has raised a total of $45.8M across 1 funding round:
Series B
$45.8M
Series B (2023): $45.8M with participation from Unorthodox Ventures, Supernova Invest, Panakes Partners, The European Innovation Council, and Relyens en France
Key Investors in CarThera
Unorthodox Ventures
Unorthodox Ventures is a venture capital firm specializing in early-stage medical and construction technology, with a focus on innovations in cardio and gastrointestinal health. They provide resources such as public relations, manufacturing assistance, and go-to-market strategies to support their portfolio companies.
Supernova Invest
Supernova Invest provides expertise and patient capital to deeptech leaders in Industrial Technologies, Digital, Healthcare, and Cleantech sectors, supporting high-growth startups with a focus on shaping the future of industry.
Panakes Partners
Panakès Partners is a European and Israeli venture capital investor focused on financing early-stage medical companies, startups, and SMEs with promising products that improve patient outcomes and healthcare economics.
What's next for CarThera?
With this substantial strategic investment, CarThera is poised for significant expansion and further development of its proprietary ultrasound technology. The company's trajectory suggests a focus on scaling operations, advancing its product pipeline, and potentially exploring new therapeutic applications. This backing from prominent investors indicates strong confidence in CarThera's ability to achieve its long-term objectives and make a lasting impact on patient care.
See full CarThera company page
